Mor Yong opens conditions for risk groups What kind of drug to treat COVID-19 BA.5 should be used?

Mor Yong opens conditions for risk groups What kind of drug to treat COVID-19 BA.5 should be used?

Omicron BA.5 is a serious epidemic. “Doctor Yong” emphasizes that besides vaccination Requires special care for high-risk groups along with recommending the use of each type of treatment When should I use it? “Nation Online” is compiled here. Covid BA.5, a subspecies of Omicron, has spread more recently. Prof. Dr. Yong Phuworawan or “Mor Yong”, head of the center specializes in clinical virology. Department of Pediatrics Faculty […]

Read more
How voluntary licensing agreements are transforming HIV care

How voluntary licensing agreements are transforming HIV care

BARCELONA — In 2014, ViiV Healthcare, a pharmaceutical company dedicated to ending the HIV epidemic, and the Medicines Patent Pool, an organization funded primarily by Unitaid to increase access to medicines in lower-income countries, signed two voluntary licensing agreements. The agreements allowed generic manufacturers to produce and sell low-cost versions of the ViiV-developed HIV drug dolutegravir in all low- […]

Read more
Antifungal and antidepressant drugs can effectively inhibit COVID-19 virus

Antifungal and antidepressant drugs can effectively inhibit COVID-19 virus

New research published in the British Journal of Pharmacology indicates that two currently available medications–an antifungal drug and an antidepressant–can effectively inhibit the virus that causes COVID-19 in laboratory cells. Investigators found that the antifungal itraconazole and the antidepressant fluoxetine each blocked the production of infectious SARS-CoV-2 virus in cell culture lab tests. When either […]

Read more